An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion

1 day ago 5

Jonathan Ponciano, The Motley Fool

Sun, August 2, 2026 astatine 2:51 PM CDT 5 min read

Chairman and CEO Ari Bousbib reported a merchantability of astir 106,000 shares of IQVIA Holdings Inc. (NYSE:IQV) for full proceeds of $26.1 cardinal successful an SEC Form 4 filing.

Transaction summary

Transaction worth based connected SEC Form 4 weighted mean merchantability terms ($245.51); post-transaction worth based connected July 29, 2026 marketplace adjacent ($247.56).

Key questions

  • What was the operation of this disposition?
    The transaction was an exercise-and-sell of banal appreciation rights expiring successful February 2027, wherever 106,279 shares were sold astatine a weighted mean terms of $245.51.

  • How does this interaction the insider's full equity exposure?
    While nonstop holdings were reduced by 11%, the insider retains a full beneficial presumption of 1.4 cardinal shares, including important indirect interests that remained unchanged.

  • What is the value of the Orohena Trust holdings?
    Bousbib maintains indirect ownership of 543,000 shares done the Orohena Trust, providing continued semipermanent vulnerability to the company's valuation abstracted from nonstop enforcement compensation.

  • How does the execution terms comparison to caller marketplace valuation?
    The shares were sold astatine a weighted mean terms of $245.51, representing a constrictive discount to the $247.56 marketplace adjacent connected the July 29, 2026 transaction date.

Company Overview

Company Snapshot

  • IQVIA provides blase analytical insights, precocious exertion solutions, and broad objective probe services to the beingness sciences manufacture done 3 superior operating segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

  • The institution generates gross done a diversified concern exemplary that combines information analytics, exertion platforms, objective proceedings services, and income unit outsourcing solutions for pharmaceutical, biotechnology, and aesculapian instrumentality manufacturers globally.

  • IQVIA serves pharmaceutical companies, biotechnology firms, aesculapian instrumentality manufacturers, and healthcare organizations crossed the Americas, Europe, Africa, and Asia-Pacific regions, positioning itself arsenic a captious spouse successful cause improvement and commercialization.

Read Entire Article